CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 206 enrolled
Drug / intervention
RF ablation, using specialized CFAE softwareprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00812916
NCT00812916N/ACompleted

EXPRESSO - European Carto® XP REgistry for Validating Specialized CFAE SOftware

Biosense Webster EMEA·observational·Posted Dec 22, 2008·Updated Feb 8, 2016

In Brief

An observational study evaluating RF ablation, using specialized CFAE software for Atrial Fibrillation. Completed, enrolled 206 participants across 13 sites in 3 countries.

Detailed Summary

The purpose of this prospective observational study (registry) is to determine the acute success rate of a complex fractionated atrial electrogram (CFAE) guided ablation procedure using a dedicated software and to determine the functionality and performance of the CFAE software in patients with a type of persistent atrial fibrillation (AF) in routine clinical practice.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance, Germany, Hungary
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 22, 2008
Enrollment StartSep 1, 2008
Primary CompletionSep 1, 2010
Study CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 17.5 years ago

Interventions

RF ablation, using specialized CFAE softwareprocedure

RF ablation